Cell Separation Technologies Market Growth, Investments and Key Players

Answer : The global enzyme-linked immunosorbent assay (ELISA) testing market size was valued at USD 1.63 billion in 2020 and is predicted to reach USD 4.02 billion by the end of 2030, representing impressive CAGR of 6.4% during the forecast period 2021 to 2030.

Answer : The global enzyme-linked immunosorbent assay (ELISA) testing market is representing impressive CAGR of 6.4% during the forecast period 2021 to 2030.

Answer : Factors such as growingincidence of infectious disorders such as hepatitis, dengue, and AIDS, increasing prevalence of neurological disorders, growing geriatric population, high research and development expenditure of major players, growing per capita healthcare spending, growing incidence of non-communicable diseases, and emergence of cost-effective technologies are driving the growth of enzyme-linked immunosorbent assay (ELISA) testingmarket.Increasing focus on laboratory automation and growing R&D activities in monoclonal antibodies (mABs) and biomarkers are further propelling the enzyme-linked immunosorbent assay (ELISA) testingmarket expansion across the globe. The most important advantage of using ELISA is its specificity and sensitivity with antibodies that are customized for a spec

Answer : In 2020, North America dominated the global market with a market share of more than 42%.

Answer : The Asia Pacific region is projected to lead with highest CAGR of about 7.8% in the estimate duration majorly because of high frequency of infectious ailments.African, Latin American, and Middle Eastern region will display perceptible progress.

Answer : The major companies operating in the worldwide enzyme-linked immunosorbent assay (ELISA) test market are ZEUS Scientific, Inc., Thermo Fisher Scientific, Inc., R&D Systems, Inc., American Laboratory Products Company (ALPCO), Bio-Rad Laboratories, Inc., BD, BioMérieux SA, and Ortho Clinical Diagnostics, among others.

Answer : Enzyme-Linked Immunosorbent Assay (ELISA) also named enzyme immunoassay (EIA) is a plate-based assay procedure for discovery and evaluation of substances such as antibodies, hormones, proteins, etc. The ELISA has been employed widely as a significant diagnostic instrument in plant pathology, medicine, as well as a quality-control audit in biotech and pharmaceutical industries. ELISA assay procedure is based on precise antigen antibody attachment. The antigen, to be evaluated, is immobilized on a solid surface and then is complexed with antibody which is linked to an enzyme. Recognition is accomplished by measuring the coupled enzyme activity via incubation with a substrate to manufacture a product that can be calculated. ELISA has usage in various domains such as allergen recognition in th